 |
市場調查報告書
商品編碼
1401003
四肢癱瘓治療市場，按治療類型、按給藥途徑、按配銷通路、按國家和地區分類 - 2023-2030 年行業分析、市場規模、市場佔有率和預測Quadriplegia Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030 |
||||||
報告要點
2022 年四肢癱瘓治療市場規模為 14.684 億美元，2023 年至 2030 年CAGR為 4.3%。
四肢癱瘓治療市場-市場動態
神經假體和腦機介面（BCI）技術的快速發展推動市場需求
革命性的方法允許大腦和外部設備直接接觸，為四肢癱瘓患者恢復肢體功能和運動帶來希望。推動力是科學進步和患者對更多自由的不斷成長的需求的結合。研究人員、神經科學家和公司正在大力投資開發更複雜的腦機介面和神經義肢，其動機是改善四肢癱瘓患者的生活品質並開闢神經復健的新領域，使以前難以想像的恢復水平成為現實。
四肢癱瘓治療市場 - 主要見解
根據我們的研究分析師分享的分析，預計全球四肢癱瘓治療市場在預測期內（2023-2030）每年將以 4.3% 左右的CAGR成長
由於神經假體和腦機介面（BCI）技術的快速發展，四肢癱瘓治療產業預計將以顯著的速度成長
根據治療類型細分，預計皮質類固醇將在 2022 年顯示最大的市場佔有率
根據給藥途徑細分，口服是 2022 年領先的治療類型
按地區分類，亞太地區是 2022 年領先的收入來源
四肢癱瘓治療市場-細分分析：
全球四肢癱瘓治療市場根據治療類型、給藥途徑、配銷通路和區域進行細分。
根據治療類型，市場分為六類：皮質類固醇、非類固醇抗發炎藥、抗憂鬱藥、抗驚厥藥、麻醉鎮痛藥、解痙藥和肌肉鬆弛藥。皮質類固醇在市場上佔主導地位。四肢癱瘓治療中皮質類固醇療法供不應求。皮質類固醇因其抗發炎特性而被廣泛用於治療急性脊髓損傷，但其療效甚微。其他治療方法，包括物理治療、輔助裝置和神經復健程序，在提高四肢癱瘓患者的功能和生活品質方面發揮更大的作用。
根據給藥途徑，市場分為兩類：口服、靜脈注射。口腔產業在市場中佔據主導地位，並可能在預測期內保持其主導地位。口服療法很少用於四肢癱瘓治療，因為它們無法成功解決這種疾病的根本原因，即脊髓損傷。物理治療、輔助設備和更專業的治療是主要的治療重點，口服藥物在四肢癱瘓的治療中只佔一小部分。
四肢癱瘓治療市場 - 地理洞察
從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。有幾個變數影響亞太地區四肢癱瘓治療的需求。該地區人口規模較大，因事故等原因造成不同程度的脊髓損傷。此外，由於醫療基礎設施的改善和專業復健服務的提供，人們對完全四肢癱瘓治療的認知和需求不斷成長。此外，輔助技術的進步，包括外骨骼和神經假體，作為提高該地區四肢癱瘓者生活品質的可行解決方案而受到關注。最後，人口老化可能會增加對有效療法的需求，以解決與年齡相關的脊髓損傷和退化性疾病的影響。
四肢癱瘓治療市場-競爭格局：
醫療保健提供者、復健中心、輔助科技製造商和研究機構構成了四肢癱瘓治療的競爭環境。例如，ReWalk Robotics 和 Ekso Bionics 專門製造機器人外骨骼以改善運動。邁阿密治癒癱瘓計畫和克里斯多福和達納里夫基金會贊助開發四肢癱瘓療法的研究。甘迺迪克里格研究所等復健中心提供綜合治療和治療。這些參與者之間正在該領域合作，開發神經修復術和再生醫學等創新療法，目標是改善四肢癱瘓患者的獨立性和康復能力，並擴大這一專業醫療保健領域的可用選擇。
目錄
第1章：四肢癱瘓治療市場概述
- 研究範圍
- 市場預估年份
第 2 章：執行摘要
- 市場片段
- 四肢癱瘓治療市場片段（依治療類型）
- 四肢癱瘓治療市場片段（依給藥途徑）
- 四肢癱瘓治療市場片段（按配銷通路）
- 四肢癱瘓治療市場片段（按國家/地區）
- 按地區分類的四肢癱瘓治療市場片段
- 競爭洞察
第 3 章：四肢癱瘓治療主要市場趨勢
- 四肢癱瘓治療市場促進因素
- 市場促進因素的影響分析
- 四肢癱瘓治療市場限制
- 市場限制影響分析
- 四肢癱瘓治療市場機會
- 四肢癱瘓治療市場未來趨勢
第 4 章：四肢癱瘓治療產業研究
- PEST分析
- 波特五力分析
- 成長前景圖
- 規範架構分析
第 5 章：四肢癱瘓治療市場：COVID-19 影響分析
- COVID-19 之前的影響分析
- COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔
第 6 章：四肢癱瘓治療市場模式
- 2022 年四肢癱瘓治療市佔率分析
- 按主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析
第 7 章：四肢癱瘓治療市場 - 按治療類型
- 概述
- 按治療類型分類的細分市場佔有率分析
- 皮質類固醇
- 非類固醇抗發炎藥
- 抗憂鬱藥
- 抗驚厥藥
- 麻醉鎮痛藥
- 解痙藥和肌肉鬆弛藥
第 8 章：四肢癱瘓治療市場 - 按給藥途徑
- 概述
- 按給藥途徑分類的細分市佔率分析
- 口服
- 靜脈
第 9 章：四肢癱瘓治療市場 - 按配銷通路
- 概述
- 按配銷通路分類的細分市場佔有率分析
- 醫院
- 藥局
- 零售藥局
- 藥局
- 網路商店
第 10 章：四肢癱瘓治療市場 - 按地理位置
- 介紹
- 按地理位置分類的細分市場佔有率分析
- 北美洲
- 概述
- 北美四肢癱瘓治療主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按治療類型）
- 北美市場規模與預測（按管理途徑）
- 北美市場規模和預測（按配銷通路）
- 美國
- 加拿大
- 歐洲
- 概述
- 歐洲四肢癱瘓治療主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按治療類型）
- 歐洲市場規模與預測（按管理途徑）
- 歐洲市場規模和預測（按配銷通路）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
- 亞太地區 (APAC)
- 概述
- 亞太地區四肢癱瘓治療主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按治療類型）
- 亞太地區市場規模與預測（依管理途徑）
- 亞太地區市場規模和預測（按配銷通路）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
- 拉丁美洲
- 概述
- 拉丁美洲四肢癱瘓治療主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按治療類型）
- 拉丁美洲市場規模與預測（按管理途徑）
- 拉丁美洲市場規模和預測（按配銷通路）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
- 中東和非洲
- 概述
- 中東和非洲四肢癱瘓治療主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按治療類型）
- 中東和非洲市場規模及預測（按管理途徑）
- 中東和非洲市場規模及預測（按配銷通路）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分
第 11 章：主要供應商分析 - 四肢癱瘓治療產業
- 競爭儀表板
- 公司簡介
- ReWalk Robotics
- Ekso Bionics
- Cyberdyne Inc.
- Invacare Corporation
- Hocoma AG
- Axogen Corporation
- Myomo Inc.
- Ossur
- Parker Hannifin
- InVivo Therapeutics
- University of California, Los Angeles (UCLA)
- The Miami Project to Cure Paralysis
- Kennedy Krieger Institute
- Cleveland Clinic
- Swiss Paraplegic Centre
第 12 章：360 度分析師視角
第 13 章：附錄
- 研究方法論
- 參考
- 縮寫
- 免責聲明
- 聯絡我們
REPORT HIGHLIGHT
Quadriplegia Treatment Market size was valued at USD 1,468.4 Million in 2022, expanding at a CAGR of 4.3 % from 2023 to 2030.
Quadriplegia therapy is a complex strategy to address the physical and functional restrictions caused by severe spinal cord injuries, which normally affect all four limbs and often end in considerable paralysis. While comprehensive treatments are presently unattainable, quadriplegia therapy focuses on improving afflicted persons' quality of life and independence. This encompasses physical therapy, assistive devices, mobility aids, and sophisticated technology including exoskeletons and neuroprosthetics. In addition, continuing research looks at regenerative medicine, brain interfaces, and other novel therapies to help quadriplegics regain function and autonomy.
Quadriplegia Treatment Market- Market Dynamics
Rapid development of neuroprosthetic and brain-computer interface (BCI) technologies propel market demand
Revolutionary methods allow direct contact between the brain and external equipment, providing hope for quadriplegics to regain limb function and movement. The driving force is a combination of scientific advancements and growing demand from patients desiring more freedom. Researchers, neuroscientists, and companies are investing heavily in the development of more sophisticated BCIs and neuroprosthetics, motivated by the desire to improve the quality of life for quadriplegics and open up new frontiers in neural rehabilitation, allowing previously unimaginable levels of restoration to become a reality.
Quadriplegia Treatment Market- Key Insights
As per the analysis shared by our research analyst, the global Quadriplegia Treatment market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2023-2030)
The Quadriplegia Treatment industry is projected to grow at a significant rate due to rapid development of neuroprosthetic and brain-computer interface (BCI) technologies
Based on Treatment Type segmentation, Corticosteroids was predicted to show maximum market share in the year 2022
Based on Route of Administration segmentation, Oral was the leading Treatment Type in 2022
On the basis of region, Asia Pacific was the leading revenue generator in 2022
Quadriplegia Treatment Market- Segmentation Analysis:
The Global Quadriplegia Treatment Market is segmented on the basis of Treatment Type, Route of Administration, Distribution Channel, and Region.
The market is divided into six categories based on Treatment Type: Corticosteroids, Non- Steroidal Anti-inflammatory Drugs, Antidepressants, Anticonvulsants, Narcotic Analgesics, Antispasmodics & Muscle Relaxants. The Corticosteroids dominates the market. Corticosteroid therapies are in short supply in quadriplegia therapy. Corticosteroids are largely utilized for their anti-inflammatory qualities in the treatment of acute spinal cord injuries, however they have demonstrated minimal efficacy. Other treatment methods, including as physical therapy, assistive devices, and neurorehabilitation procedures, play a larger role in increasing quadriplegic people' function and quality of life.
The market is divided into two categories based on Route of Administration: Oral, Intravenous. The Oral sector dominates the market and is likely to maintain its dominance during the forecast period. Oral therapies are seldom used in quadriplegia therapy because they are unsuccessful in addressing the underlying causes of this disorder, which are spinal cord injuries. Physical therapy, assistive devices, and more specialized therapies are the primary treatment focuses, with oral drugs having a minor part in quadriplegia management.
Quadriplegia Treatment Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables impact the need for quadriplegia therapy in the Asia-Pacific area. The region has a sizable population with varied degrees of spinal cord injury caused by accidents and other reasons. Furthermore, growing awareness and demand for complete quadriplegia therapy have resulted from improved healthcare infrastructure and the availability of specialized rehabilitation services. Additionally, advances in assistive technology, including as exoskeletons and neuroprosthetics, are gaining traction as viable solutions to enhance the quality of life for quadriplegic people in the area. Finally, an aging population may increase the need for effective therapies to address the effects of age-related spinal cord injuries and degenerative disorders.
Quadriplegia Treatment Market- Competitive Landscape:
Healthcare providers, rehabilitation centers, assistive technology manufacturers, and research organizations make up the competitive environment in quadriplegia therapy. ReWalk Robotics and Ekso Bionics, for example, specialize in building robotic exoskeletons to improve movement. The Miami Project to Cure Paralysis and the Christopher and Dana Reeve Foundation sponsor research to develop quadriplegia therapies. Comprehensive treatment and therapy are provided by rehabilitation centers such as the Kennedy Krieger Institute. Collaboration between these players is taking place in the field to develop innovative treatments, such as neuroprosthetics and regenerative medicine, with the goal of improving independence and rehabilitation for quadriplegic individuals and expanding the range of available options in this specialized healthcare domain.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL QUADRIPLEGIA TREATMENT MARKET KEY PLAYERS
- ReWalk Robotics
- Ekso Bionics
- Cyberdyne Inc.
- Invacare Corporation
- Hocoma AG
- Axogen Corporation
- Myomo Inc.
- Ossur
- Parker Hannifin
- InVivo Therapeutics
- University of California, Los Angeles (UCLA)
- The Miami Project to Cure Paralysis
- Kennedy Krieger Institute
- Cleveland Clinic
- Swiss Paraplegic Centre
GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY TREATMENT TYPE
- Corticosteroids
- Non- Steroidal Anti-inflammatory Drugs
- Antidepressants
- Anticonvulsants
- Narcotic Analgesics
- Antispasmodics & Muscle Relaxants
GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
- Oral
- Intravenous
GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL
- Hospital
- Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Stores
GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Quadriplegia Treatment Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Quadriplegia Treatment Market Snippet by Treatment Type
- 2.1.2. Quadriplegia Treatment Market Snippet by Route of Administration
- 2.1.3. Quadriplegia Treatment Market Snippet by Distribution Channel
- 2.1.4. Quadriplegia Treatment Market Snippet by Country
- 2.1.5. Quadriplegia Treatment Market Snippet by Region
- 2.2. Competitive Insights
3. Quadriplegia Treatment Key Market Trends
- 3.1. Quadriplegia Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Quadriplegia Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Quadriplegia Treatment Market Opportunities
- 3.4. Quadriplegia Treatment Market Future Trends
4. Quadriplegia Treatment Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Quadriplegia Treatment Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Quadriplegia Treatment Market Landscape
- 6.1. Quadriplegia Treatment Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Quadriplegia Treatment Market - By Treatment Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
- 7.1.2. Corticosteroids
- 7.1.3. Non- Steroidal Anti-inflammatory Drugs
- 7.1.4. Antidepressants
- 7.1.5. Anticonvulsants
- 7.1.6. Narcotic Analgesics
- 7.1.7. Antispasmodics & Muscle Relaxants
8. Quadriplegia Treatment Market - By Route of Administration
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
- 8.1.2. Oral
- 8.1.3. Intravenous
9. Quadriplegia Treatment Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
- 9.1.2. Hospital
- 9.1.3. Pharmacies
- 9.1.4. Retail Pharmacies
- 9.1.5. Drug Stores
- 9.1.6. Online Stores
10. Quadriplegia Treatment Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Quadriplegia Treatment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Quadriplegia Treatment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Quadriplegia Treatment Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Quadriplegia Treatment Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Quadriplegia Treatment Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Quadriplegia Treatment Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. ReWalk Robotics
- 11.2.2. Ekso Bionics
- 11.2.3. Cyberdyne Inc.
- 11.2.4. Invacare Corporation
- 11.2.5. Hocoma AG
- 11.2.6. Axogen Corporation
- 11.2.7. Myomo Inc.
- 11.2.8. Ossur
- 11.2.9. Parker Hannifin
- 11.2.10. InVivo Therapeutics
- 11.2.11. University of California, Los Angeles (UCLA)
- 11.2.12. The Miami Project to Cure Paralysis
- 11.2.13. Kennedy Krieger Institute
- 11.2.14. Cleveland Clinic
- 11.2.15. Swiss Paraplegic Centre
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data Route of Administrations
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Quadriplegia Treatment Market: Treatment Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Treatment Type
- TABLE Global Quadriplegia Treatment Market, by Treatment Type 2018-2030 (USD Million)
- TABLE Quadriplegia Treatment Market: Route of Administration Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Route of Administration
- TABLE Global Quadriplegia Treatment Market, by Route of Administration 2018-2030 (USD Million)
- TABLE Quadriplegia Treatment Market: Distribution Channel Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
- TABLE Global Quadriplegia Treatment Market, by Distribution Channel 2018-2030 (USD Million)
- TABLE Quadriplegia Treatment Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Quadriplegia Treatment Market, by Region 2018-2030 (USD Million)
- TABLE North America Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE North America Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE North America Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
- TABLE North America Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Europe Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Europe Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
- TABLE Europe Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Asia Pacific Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
- TABLE Asia Pacific Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Latin America Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Latin America Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
- TABLE Latin America Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Middle East and Africa Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
- TABLE Middle East and Africa Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
![顏面神經麻痺市場規模 - 類型（貝爾氏麻痺、後天性顏面神經麻痺、先天性顏面神經麻痺）、管理類型（治療[藥物、手術]、診斷）、最終使用者（醫院、門診手術中心、專科診所）和預測，2024 - 2032](/sample/img/cover/42/1513594.png)
